Business Description
Cassava Sciences Inc
NAICS : 325412
SIC : 2834
ISIN : US14817C1071
Description
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.75 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -112.6 | |||||
| 3-Year EPS without NRI Growth Rate | -109.3 | |||||
| 3-Year FCF Growth Rate | -112.1 | |||||
| 3-Year Book Growth Rate | 7.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 5.32 | |||||
| 9-Day RSI | 11.44 | |||||
| 14-Day RSI | 16.45 | |||||
| 6-1 Month Momentum % | 43.23 | |||||
| 12-1 Month Momentum % | 3.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.55 | |||||
| Quick Ratio | 3.55 | |||||
| Cash Ratio | 2.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.2 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -12.15 | |||||
| ROA % | -9.32 | |||||
| ROIC % | -377.82 | |||||
| ROC (Joel Greenblatt) % | -623.64 | |||||
| ROCE % | -92.69 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 28.63 | |||||
| Price-to-Owner-Earnings | 7.24 | |||||
| PB Ratio | 0.69 | |||||
| Price-to-Tangible-Book | 0.69 | |||||
| EV-to-EBIT | 0.04 | |||||
| EV-to-EBITDA | 0.04 | |||||
| EV-to-Forward-Revenue | 0.63 | |||||
| EV-to-FCF | 0.1 | |||||
| Price-to-Net-Current-Asset-Value | 0.79 | |||||
| Price-to-Net-Cash | 1.26 | |||||
| Earnings Yield (Greenblatt) % | 2613.89 | |||||
| FCF Yield % | -66.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cassava Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.256 | ||
| Beta | -2.05 | ||
| Volatility % | 96.71 | ||
| 14-Day RSI | 16.45 | ||
| 14-Day ATR (€) | 0.860119 | ||
| 20-Day SMA (€) | 2.9773 | ||
| 12-1 Month Momentum % | 3.21 | ||
| 52-Week Range (€) | 2.194 - 38 | ||
| Shares Outstanding (Mil) | 48.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cassava Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cassava Sciences Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cassava Sciences Inc Frequently Asked Questions
What is Cassava Sciences Inc(FRA:PX91)'s stock price today?
The current price of FRA:PX91 is €2.19. The 52 week high of FRA:PX91 is €38.00 and 52 week low is €2.19.
When is next earnings date of Cassava Sciences Inc(FRA:PX91)?
The next earnings date of Cassava Sciences Inc(FRA:PX91) is 2025-02-28 Est..
Does Cassava Sciences Inc(FRA:PX91) pay dividends? If so, how much?
Cassava Sciences Inc(FRA:PX91) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers